期刊文献+

WHO《潜伏性结核感染管理指南》要点解析及我国研究现状 被引量:31

The point analysis for Guidelines on the management of latent tuberculosis infection of World Health Organizationand the research status in China
下载PDF
导出
摘要 为了更好地遏制活动性结核病,2015年初世界卫生组织发布了《潜伏性结核感染管理指南》(简称“《指南》”)。笔者就该《指南》中如何界定高危人群、潜伏性感染的筛查流程和筛查手段、预防性治疗方案等进行详细解析;同时介绍了我国的研究现状,以期能为我国的潜伏性结核感染的管理提供参考。 For better stopping active tuberculosis, Guidelines on the management of latent tuberculosis infection (“Guidelines” for short) was released by the World Health Organization in 2015. The author expained the points of the Guidelines about identification of at-risk populations for LTBI, algorithm to test LTBI, screening and treatment options and the research status in China, in order to provide a reference for the management of LTBI in China.
作者 裴宁 卢水华
出处 《中国防痨杂志》 CAS 2015年第7期736-739,共4页 Chinese Journal of Antituberculosis
关键词 潜伏性结核/预防和控制 临床方案 Latent tuberculosis/prevention & control Clinical protocols
  • 相关文献

参考文献18

  • 1Mack U, Migliori GB, Sester M, et al. LTBh latent tubercu- losis infection or lasting immune response to M. tuberculosis? A TBNET consensus statment. Eur Respir J, 2009,33 (5) : 956-973.
  • 2Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, Sexual Transmitted Diseases and Tuberculosis Prevention. Latent tuberculosis infection., a guide for primary health care providers. Atlanta: Centers for Disease Control and Prevention, 2013.
  • 3World Health Organization. Guidelines on the management of latent tuberculosis infection. WHO/HTM/TB/2015.01. Ge- neva.World Health Organization,2015.
  • 4Dye C, Scheele S, Dolin P, et al. Consensus statement. Glo- bal burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Mo- nitoring Project. JAMA, 1999, 282(7).677-686.
  • 5屠德华,万利亚,王黎霞.现代结核病控制理论与实践.2版.北京:军事医学科学出版社,2013:1-8.
  • 6张贺秋,赵雁林.现代结核病诊断技术.北京:人民卫生出版社,2013:47-103.
  • 7Gao XF, Wang L, Liu GJ, et al. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a me- ta-analysis. Int J Tubere Lung Dis, 2006, 10(10) : 1080-1090.
  • 8Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med, 2011, 365(23):2155-2166.
  • 9Gao L, Lu W, Bai L, et al. Latent tuberculosis infection in ru- ral China: baseline results of a population-based, multieentre, prospective cohort study. Lancet Infect Dis, 2015, 15 (3): 310-319.
  • 10无.γ-干扰素释放试验在中国应用的建议[J].中华结核和呼吸杂志,2014,37(10):744-747. 被引量:148

二级参考文献107

共引文献293

同被引文献289

引证文献31

二级引证文献192

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部